We are live on ! Find out more
PCYC

PHARMACYCLICS INC
PCYC

Delisted

PCYC was delisted on the 22nd of May, 2015.

224 hedge funds and large institutions have $6.59B invested in PHARMACYCLICS INC in 2013 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 67 increasing their positions, 87 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 48 (+4)

83% more first-time investments, than exits

New positions opened: 55 | Existing positions closed: 30

70% more capital invested

Capital invested by funds: $3.88B → $6.59B (+$2.72B)

11% more funds holding

Funds holding: 201224 (+23)

23% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 87

35% less call options, than puts

Call options by funds: $138M | Put options by funds: $211M

Holders
224
Holders Change
+23
Holders Change %
+11.44%
% of All Funds
7.26%
Holding in Top 10
8
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+100%
% of All Funds
0.26%
New
55
Increased
67
Reduced
87
Closed
30
Calls
$138M
Puts
$211M
Net Calls
-$73.4M
Net Calls Change
-$35.3M
Name Holding Trade Value Shares
Change
Change in
Stake
ST
201
Spot Trading
Illinois
$71K -$6.66K -60 -10%
CCM
202
Chilton Capital Management
Texas
$69.1K
Fifth Third Bancorp
203
Fifth Third Bancorp
Ohio
$69K +$55.4K +499 New
PSI
204
Pinnacle Summer Investments
Virginia
$62K +$49.9K +450 New
BJ
205
BlackRock Japan
Japan
$56K +$44.6K +402 New
Schroder Investment Management Group
206
Schroder Investment Management Group
United Kingdom
$54.1K +$43.4K +391 New
ClearBridge Investments
207
ClearBridge Investments
New York
$49K +$39.1K +352 New
TRCT
208
Tower Research Capital (TRC)
New York
$43K +$23.5K +212 +212%
LTFS
209
Ladenburg Thalmann Financial Services
Florida
$41K +$11.1K +100 +50%
STC
210
SEI Trust Company
Pennsylvania
$35K -$41.8K -377 -60%
CGT
211
Capital Guardian Trust
California
$30K
PTC
212
Private Trust Company
Ohio
$28K -$2.77K -25 -11%
VCM
213
Vigilant Capital Management
Maine
$28K
HNB
214
Huntington National Bank
Ohio
$28K +$12.3K +111 +119%
MFS
215
MSI Financial Services
Massachusetts
$24K +$18.9K +170 New
MA
216
MUFG Americas
New York
$19K +$15.5K +140 New
FWM
217
Focused Wealth Management
New York
$14K +$11.1K +100 New
First Manhattan
218
First Manhattan
New York
$8K
EFSCE
219
Enterprise Financial Services Corp (EFSC)
Missouri
$6K +$4.99K +45 New
Northwestern Mutual Wealth Management
220
Northwestern Mutual Wealth Management
Wisconsin
$5K +$4.66K +42 New
Envestnet Asset Management
221
Envestnet Asset Management
Illinois
$2K
FNBT
222
FineMark National Bank & Trust
Florida
$1K +$555 +5 New
Victory Capital Management
223
Victory Capital Management
Texas
$1K +$1.11K +10 New
Manulife (Manufacturers Life Insurance)
224
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$293 +$6.44K +58 +3%
Capital Fund Management (CFM)
225
Capital Fund Management (CFM)
France
-$10.7M -134,532 Closed

PCYC Hedge Fund Activity: Q3 2013 in Review

224 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in PHARMACYCLICS INC (PCYC) for Q3 2013, worth a combined $6.59B — up 70% from $3.88B a quarter earlier.

Buyers outnumbered sellers: 55 funds opened new PCYC positions and 30 closed out — a net gain of 25 holders — while 67 added to existing stakes and 87 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $179M. The largest seller was Baker Bros. Advisors, cutting an estimated $195M.

  • 224 institutional investors held PHARMACYCLICS INC (PCYC) as of Q3 2013, up from 201 in Q2 2013.
  • Funds reported $6.59B of PHARMACYCLICS INC stock for Q3 2013, up 70% quarter-over-quarter.
  • 55 funds opened new PHARMACYCLICS INC positions in Q3 2013 and 30 closed out, a net change of +25 holders.
  • The largest PHARMACYCLICS INC buyer in Q3 2013 was Fidelity Investments, an estimated $179M added.
  • The largest PHARMACYCLICS INC seller in Q3 2013 was Baker Bros. Advisors, an estimated $195M sold.

Based on aggregated 13F filings for Q3 2013.